The Cigna Group (CI) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 282.38B USD | |
| Cost of products and services | 224.13B USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $282.38B | $224.13B | (m) |
| 2026-03-31 | (m) | $277.89B | $220.69B | (m) |
| 2025-12-31 | (m) | $274.90B | $214.99B | (m) |
| 2025-09-30 | (m) | $268.08B | $206.22B | (m) |
| 2025-06-30 | (m) | $262.02B | $198.25B | (m) |
| 2025-03-31 | (m) | $255.37B | $189.48B | (m) |
| 2024-12-31 | (m) | $247.12B | $182.51B | (m) |
| 2024-09-30 | (m) | $232.59B | $168.75B | (m) |
| 2024-06-30 | (m) | $217.94B | $154.82B | (m) |
| 2024-03-31 | (m) | $206.00B | $143.77B | (m) |
| 2023-12-31 | (m) | $195.26B | $133.80B | (m) |
| 2023-09-30 | (m) | $189.90B | $130.63B | (m) |
| 2023-06-30 | (m) | $186.13B | $128.77B | (m) |
| 2023-03-31 | (m) | $183.03B | $126.48B | (m) |
| 2022-12-31 | (m) | $180.52B | $124.83B | (m) |
| 2022-09-30 | (m) | $180.45B | $123.99B | (m) |
| 2022-06-30 | (m) | $179.46B | $122.28B | (m) |
| 2022-03-31 | (m) | $177.11B | $120.13B | (m) |
| 2021-12-31 | (m) | $174.08B | $117.55B | (m) |
| 2021-09-30 | (m) | $170.10B | $113.36B | (m) |
| 2021-06-30 | (m) | $166.77B | $109.92B | (m) |
| 2021-03-31 | (m) | $162.90B | $106.53B | (m) |
| 2020-12-31 | (m) | $160.40B | $103.48B | (m) |
| 2020-09-30 | (m) | $156.93B | $100.53B | (m) |
| 2020-06-30 | (m) | $154.53B | $98.46B | (m) |
| 2020-03-31 | (m) | $154.09B | $97.81B | (m) |
| 2019-12-31 | (m) | $153.57B | $97.67B | (m) |
| 2019-09-30 | (m) | $129.62B | $76.58B | (m) |
| 2019-06-30 | (m) | $102.52B | $52.63B | (m) |
| 2019-03-31 | (m) | $75.18B | $28.28B | (m) |
| 2018-12-31 | (m) | $48.65B | $4.79B | (m) |
| 2018-09-30 | (m) | $44.98B | (m) | (m) |
| 2018-06-30 | (m) | $43.90B | (m) | (m) |
| 2018-03-31 | (m) | $42.79B | (m) | (m) |
| 2017-12-31 | (m) | $41.81B | $2.46B | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $39.84B | $2.47B | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |